Business

Correction : Holding(s) in Company

Correction : Holding(s) in Company.

articleProteome Sciences PlcFebruary 26, 20095/company/proteome-sciences-plc/news/correction-holdings-in-company-22
Correction : Holding(s) in Company

About this update from Proteome Sciences Plc

[{"type":"text","content":"\n \nThis announcement replaces the announcement released 26 February at 09.00. In\nthe announcement released at 09.00, the Sanofi-Aventis interest holdings was\nincorrectly stated as having crossed the 9% threshold. The correct threshold\ncrossed is 10%\n\n\n\nFor filings with the FSA include the annex \nFor filings with issuer exclude the annex \n\nTR-1: Notifications of Major Interests in Shares \n\n1. Identity of the issuer or the underlying issuer of existing \nshares to which voting rights are attached: \n \nProteome Sciences plc \n \n2. Reason for notification [Yes/No] \n \nAn acquisition or disposal of voting rights Yes \n \nAn acquisition or disposal of financial instruments which No \nmay result in the \nacquisition of shares already issued to which voting rights \nare attached \n \nAn event changing the breakdown of voting rights No \n \nOther (please specify): No \n \n3. Full name of person(s) subject to Sanofi-Aventis Deutschland GmbH \nnotification \nobligation: \n \n4. Full name of shareholder(s) (if \ndifferent from 3): \n \n5. Date of transaction (and date on 24 February 2009 \nwhich the \nthreshold is crossed or reached if \ndifferent): \n \n6. Date on which issuer notified: 25 February 2009 \n \n7. Threshold(s) that is/are crossed or 10.00% \nreached: \n\n8: Notified Details \n \nA: Voting rights attached to shares \n\nClass/type of Situation previous to Resulting situation after \nshares the triggering the triggering transaction \n transaction \n \nIf possible Number of Number of Number of Number of Percentage of \nuse shares voting shares voting rights voting rights \nISIN code rights \n \n Direct Indirect Direct Indirect\n \nGB003104196 13,663,380 13,663,380 12,286,187 12,286,187 9.25% \n \n\nB: Financial Instruments \n \nResulting situation after the triggering transaction \n\nType of Expiration Exercise/ No. of voting Percentage of \nfinancial date conversion rights that may be voting rights \ninstrument period/date acquired (if the \n instrument \n exercised/ \n converted) \n \n\nTotal (A+B) \n\nNumber of voting rights Percentage of voting rights \n \n12,286,187 9.25% \n\n9. Chain of controlled undertakings through which the voting rights and /or the\nfinancial instruments are effectively held, if applicable: \n \n\nProxy Voting: \n \n10. Name of proxy holder: \n \n11. Number of voting rights proxy \nhol...

More updates from Proteome Sciences Plc